ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 119.73%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+119.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.73B
AUM Growth
+$2.02B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$103M
2
+$103M
3
+$39.1M
4
OCUL icon
Ocular Therapeutix
OCUL
+$34.1M
5
MRUS
Merus
MRUS
+$25.2M

Top Sells

1
+$122M
2
+$117M
3
+$112M
4
BPMC
Blueprint Medicines
BPMC
+$48.1M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$27.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
26
MannKind Corp
MNKD
$1.7B
$24M 0.31%
4,468,877
-1,381,123
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$1.29B
$14.3M 0.19%
2,000,000
-2,150,000
BCRX icon
28
BioCryst Pharmaceuticals
BCRX
$1.86B
$9.49M 0.12%
1,250,000
-3,250,000
WHWK
29
Whitehawk Therapeutics
WHWK
$144M
$5.41M 0.07%
2,849,402
TNGX icon
30
Tango Therapeutics
TNGX
$1.66B
$4.58M 0.06%
+545,000
BPMC
31
DELISTED
Blueprint Medicines
BPMC
– –
-375,000
GLUE icon
32
Monte Rosa Therapeutics
GLUE
$1.46B
– –
-3,725,000
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.11B
– –
-330,000
1
2